← Back to Search

Intra-Lock Fusion Implants for Gum Disease

N/A
Recruiting
Led By Gian Pietro Schincaglia, DDS,PhD
Research Sponsored by Case Western Reserve University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 24 months
Awards & highlights

Study Summary

The objectives of this study are to analyze the oral microbiome modulations occurring during the transition from partial (with some residual teeth) to full edentulous (without remaining teeth) status and implant placement in subjects affected by severe periodontitis; to evaluate if microbiome changes in relation to the used of different implant material/surface; and to assess the variance of the changes to determine the sample size for future longitudinal prospective studies.

Eligible Conditions
  • Gum Disease
  • Microbial Colonization
  • Toothless

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oral microbiome changes in two different implant platform types
Oral microbiome composition changes in patients who are dentate, edentulous, and have dental implants
Secondary outcome measures
Sample size

Trial Design

2Treatment groups
Experimental Treatment
Group I: Tapered Pro ImplantsExperimental Treatment1 Intervention
These patients will receive Tapered Pro Implants during implant placement
Group II: Intra-Lock Fusion ImplantsExperimental Treatment1 Intervention
These patients will receive Intra-Lock Fusion Implants during implant placement

Find a Location

Who is running the clinical trial?

Case Western Reserve UniversityLead Sponsor
299 Previous Clinical Trials
260,008 Total Patients Enrolled
Gian Pietro Schincaglia, DDS,PhDPrincipal InvestigatorCase Western Reserve University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby May 2025